BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 19024573)

  • 1. [Valvular bioprostheses and anticoagulation].
    Chambaz IC; Nendaz M
    Rev Med Suisse; 2008 Oct; 4(175):2198-202. PubMed ID: 19024573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
    Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
    J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aortic bioprosthesis without early anticoagulation--risk of thromboembolism.
    Babin-Ebell J; Schmidt W; Eigel P; Elert O
    Thorac Cardiovasc Surg; 1995 Aug; 43(4):212-4. PubMed ID: 7502285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation in valvular heart disease preoperatively and postoperatively.
    Bodnar AG; Hutter AM
    Cardiovasc Clin; 1984; 14(3):247-64. PubMed ID: 6722854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years.
    Stassano P; Di Tommaso L; Monaco M; Iorio F; Pepino P; Spampinato N; Vosa C
    J Am Coll Cardiol; 2009 Nov; 54(20):1862-8. PubMed ID: 19892237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current recommendations for prevention of thromboembolism in patients with heart valve prostheses].
    Gohlke-Bärwolf C
    Z Kardiol; 2001; 90 Suppl 6():112-7. PubMed ID: 11826813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anticoagulation in patients with mechanical valve prostheses: evolving protocols with new generation devices.
    Cotrufo M; De Feo M; De Santo LS; Della Corte A; Scardone M; Costanza S
    Ital Heart J; 2005 May; 6(5):401-4. PubMed ID: 15934413
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibition of thrombocyte aggregation after heart valve replacement].
    von Schacky C
    Z Kardiol; 1998; 87 Suppl 4():46-55. PubMed ID: 9857467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Our inability to predict thromboembolic events after prosthetic valve surgery.
    Will MB; Bernacca GM; Bell EF; Tolland MM; Lowe GD; Rumley A; Murray HM; Ford I; Wheatley DJ
    J Heart Valve Dis; 2006 Jul; 15(4):570-80; discussion 580. PubMed ID: 16901057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
    Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
    J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
    Colli A; Verhoye JP; Leguerrier A; Gherli T
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):573-7. PubMed ID: 17317197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thromboembolic complications in patients with prostheses].
    Acar J
    Ann Cardiol Angeiol (Paris); 1985 Dec; 34(10):697-701. PubMed ID: 4091502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embolic complications of porcine heterograft cardiac valves.
    Jamieson WR; Janusz MT; Miyagishima RT; Munro AI; Tutassura H; Gerein AN; Burr LH; Allen P
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):626-31. PubMed ID: 7206772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic risk in patients with aortic bioprostheses.
    Edmond JJ; Greaves SC; French JK; Graham KJ; Raudkivi PJ; Blake JW; Gerber IL; Smith WM
    J Heart Valve Dis; 2004 May; 13(3):525-8. PubMed ID: 15222303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II.
    Koertke H; Zittermann A; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
    Eur Heart J; 2007 Oct; 28(20):2479-84. PubMed ID: 17890730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac valve replacement. Problems solved and unsolved.
    Borst HG; Papagiannakis N; Bedderman C; Oelert H
    Thorac Cardiovasc Surg; 1979 Apr; 27(2):76-84. PubMed ID: 451983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticoagulation in patients with cardiac valve prostheses].
    Paparella D; d'Agostino C; Schinosa Lde L
    Recenti Prog Med; 2004 Apr; 95(4):217-25; quiz 237. PubMed ID: 15147070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model of heterotopic aortic valve replacement for studying thromboembolism prophylaxis in mechanical valve prostheses.
    McKellar SH; Thompson JL; Schaff HV
    J Surg Res; 2007 Jul; 141(1):1-6. PubMed ID: 17512549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Choice of a valve prosthesis in patients between 25 and 70 years of age].
    Gandjbakhch I; Pavie A; Jault F; Vaissier E; Bors V; Cabrol C
    Ann Cardiol Angeiol (Paris); 1985 Apr; 34(4):215-7. PubMed ID: 4015009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term antithrombotic treatment in patients with valve prostheses. Practical management and complications].
    Delahaye JP; Milon H; Ffrench P; Philippe-Bert J; Malquarti V; Saradarian W
    Ann Cardiol Angeiol (Paris); 1985 Apr; 34(4):205-11. PubMed ID: 3893303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.